{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-23-000041","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.257050+00:00","generated_at":"2026-06-08T12:29:06.412385+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"USPH Q3 revenue $150M (+7.5%); adj. EBITDA $18.6M (+9.4%); GAAP EPS $0.51","bullets":["Total net revenue of $150M, up 7.5% YoY; net patient revenue from PT ops up 9.0% to $127.2M.","Adjusted EBITDA of $18.6M, up $1.6M from $17.0M in prior-year quarter.","GAAP net income attributable to USPH of $9.3M ($0.51 diluted EPS) vs $9.6M ($0.72) in Q3 2022.","Record-high third-quarter patient volume: average 29.7 visits per clinic per day, total visits up 10.8%.","Quarterly dividend of $0.43 per share declared; full-year Adjusted EBITDA guidance at $75M-$80M."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-23-000041","json":"https://secwatch.observer/filing/0000885978-23-000041.json","markdown":"https://secwatch.observer/filing/0000885978-23-000041.md","text":"https://secwatch.observer/filing/0000885978-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/0000885978-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T12:29:06.412385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"beae685e5dd99b0689379557d492930cd8e9121f","claim":"U S PHYSICAL THERAPY INC /NV updated its three and nine months ended September 30, 2023 guidance (reaffirmed).","evidence_excerpt":"reported results for the three and nine months ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/0000885978-23-000041-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}